Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The table below shows exactly what each dose group achieved at each major checkpoint in the Phase 2 trials
No other significant main effects or interactions for contextual fear conditioning were present (all p 0.353)
Longuet C, et al
Table 4: Glycemic Parameters at Final Visit (24-Week Study) of Sitagliptin in Add-on Combination Therapy with Metformin* Sitagliptin Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on the Combination of Metformin and Glimepiride A total of 441 patients with type 2 diabetes participated in a 24-week, randomized, double-blind, placebo-controlled study designed to assess the efficacy of sitagliptin in combination with glimepiride, with or without metformin
US$ 21.29
US$ 22.80
US$ 24.30
/media/img/mt/2024/10/GLP_1/original.jpg){kind=icon}
US$ 23.38
US$ 25.53
